Efficacy and safety of human soluble thrombomodulin (ART-123) for treatment of patients in France with sepsis-associated coagulopathy: post hoc analysis of SCARLET
Bruno François(Inserm), Xavier Wittebole(Cliniques Universitaires Saint-Luc), Julie Helms(Inserm), Kosuke Tanaka(Asahi Kasei (United States)), Toshihiko Kayanoki(Asahi Kasei (United States)), Jean-Baptiste Lascarrou(Centre Hospitalier Universitaire de Nantes), David Fineberg(Asahi Kasei (United States)), Jean‐Louis Vincent(Université Libre de Bruxelles), Emmanuelle Mercier(Centre Hospitalier Universitaire de Tours), Maud Fiancette(Roche (Switzerland))
Cited by 28
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure
|Intensive Care Medicine|1996|11.7k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
|New England Journal of Medicine|2001|6.1k